RxDoctor Payments Data

Marlene Tages Cordova, DO

Family Medicine · Pembroke Pines, FLNPI 1407856685

Payments from drug & device makers

$1,403in general payments, 2019–2025

Across 60 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$204
  • Exact Sciences$193
  • Lilly USA, LLC$170
  • AbbVie$162
  • Pfizer$162
  • Astellas Pharma US Inc$141
  • plus $370 from 12 others

What the payments were for

  • Food & beverage$1,403100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,403 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$53,429
Medicare patients
65
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$15,767
MounjaroTirzepatide12$12,902
Levothyroxine Sodium125$1,232
Losartan Potassium114$1,014
Liothyronine Sodium16$739
Duloxetine Hcl16$539
Amlodipine Besylate108$517
Rosuvastatin Calcium54$516
ProgesteroneProgesterone, Micronized19$475
Atorvastatin Calcium77$464
Alprazolam36$360
Estradiol15$303
Lisinopril31$301
Metoprolol Succinate37$282
Zolpidem Tartrate25$282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$204$15,76713 claims
Lilly USA, LLCMounjaro$170$12,90212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →